Changes in characteristics and body mass index-SD after guanfacine extended-release administration for ADHD children
To clarify the change in characteristics and body mass index standard deviation (BMI-SD) after guanfacine extended-release (GXR) administration for attention-deficit/hyperactivity disorder (ADHD) children, we undertook a clinical survey of ADHD…
Suggested reading